Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01109108 · ClinicalTrials.gov registry record
Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 9,000
- Enrollment target
NCT01109108: Completed study, sponsored by Boston Medical Center.
NCT01109108 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 9,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01109108 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 9,000 participants
- Enrollment target
Study Summary
The specific aim is to evaluate the impact of PCV13 as administered in the pediatric primary care clinic at Boston medical center on the serotype specific carriage of Streptococcus pneumoniae in children \< 5. Specifically the investigators will measure the decline in vaccine serotypes, the proportion of children receiving vaccine required to achieve 50% reduction in serotype specific carriage and the correlation between immunogenicity of the specific serotypes and decline in carriage. The study has been extended to complete 5 years of surveillance to determine the new SP serotype distribution at the time presumably a new equilibrium has been achieved.
Primary Outcome
Proportion of PCV13 serotypes among n=1851 children colonized with any S. pneumoniae
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,000 participants |
| Start Date | 2010-04 |
| Est. Completion | 2015-03 |
What the finished NCT01109108 record still lists
NCT01109108 is an observational study that tracks outcomes without assigning an intervention. Its 9,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01109108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01109108 about?
NCT01109108 is a clinical study titled "Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage". The specific aim is to evaluate the impact of PCV13 as administered in the pediatric primary care clinic at Boston medical center on the serotype specific carriage of Streptococcus pneumoniae in children \< 5. Specifically the investigators will measure the decline in vaccine serotypes, the proport...
What is the current status of trial NCT01109108?
This trial is currently completed. The enrollment target is 9,000 participants. The study started on 2010-04. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT01109108?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia